Akebia Therapeutics (AKBA) Stock Price & Financial Analysis
Akebia Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Akebia Therapeutics
What is the current stock price for AKBA?
As of the latest trading session, AKBA stock trades at $1.22. The 52-week range is $0.82–$4.01, with a day range of $1.19–$1.25.
What is the P/E ratio for AKBA?
The P/E ratio (Price-to-Earnings) for AKBA is shown in the Key Statistics section. This valuation metric helps compare Akebia Therapeutics, Inc. to industry peers.
Does AKBA pay dividends?
Akebia Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for AKBA?
Analyst ratings and recommendations for AKBA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of AKBA?
Akebia Therapeutics's market capitalization is $325.8M, classifying it as a small-cap company. Akebia Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.